According to a recent LinkedIn post from Zeto Inc, the company’s EEG technology was featured in the Season 2 finale of HBO Max series The Pitt. The scene reportedly depicts a high-acuity obstetric emergency in which clinicians require immediate, bedside, full-montage EEG to guide care, emphasizing speed and accessibility.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The post highlights broader issues around delays in EEG access, including situations where patients wait or must be transferred solely to obtain EEG monitoring. By stressing point-of-care EEG as a tool for real-time brain monitoring when “minutes matter,” the content suggests Zeto is positioning its solution as a critical-care enabler, which could support adoption in emergency and intensive-care settings and potentially expand its addressable market.
For investors, the appearance in a mainstream medical drama may enhance brand visibility among clinicians and hospital decision-makers, even though it is not a traditional clinical endorsement. If this exposure contributes to greater awareness of point-of-care EEG in high-acuity use cases, it could indirectly support Zeto’s commercial traction and strengthen its competitive stance within neurology and epilepsy monitoring segments.